19 June 2020 : Clinical Research
Association between Cardiorespiratory Fitness, Relative Grip Strength with Non-Alcoholic Fatty Liver Disease
Li Hao1ABCDE, Zhengzhen Wang1ACDEG*, Yan Wang1B, Juan Wang2CD, Zhipeng Zeng3FDOI: 10.12659/MSM.923015
Med Sci Monit 2020; 26:e923015
Table 2 Effects of VO2max and RGS on male study population.
| Variables | χ̄±s/M (Q1, Q3) | P | VO2max | RGS | |||
|---|---|---|---|---|---|---|---|
| Non-NAFLD | NAFLD | Non-NAFLD | NAFLD | Non-NAFLD | NAFLD | ||
| Body fat percentage, % | 20.29±5.97 | 25.73±4.65 | <0.001** | −0.27** | −0.12 | −0.52** | −0.54** |
| BMI, kg/m | 23.96±3.30 | 27.12±3.15 | <0.001** | −1.8** | −0.03 | −0.54** | −0.48** |
| WHR | 0.92±0.04 | 0.96±0.03 | <0.001** | −0.21** | −0.05 | −0.48** | −0.47** |
| SBP mmHg | 116.28±12.81 | 118.77±12.77 | 0.009** | −0.03 | 0.08 | −0.04 | −0.07 |
| DBP, mmHg | 73.93±10.77 | 76.66±11.37 | 0.001** | −0.08** | 0.05 | −0.07** | −0.09 |
| TC, mg/dL | 5.20 (4.55, 5.81) | 5.41 (4.69, 6.24) | 0.014* | −0.08 | −0.03 | −0.06 | −0.10 |
| TG, mg/dL | 1.35 (0.94, 1.92) | 2.13 (1.49, 3.20) | <0.001** | −0.22** | 0.03 | −0.25** | −0.15* |
| LDL-C, mg/dL | 3.24±0.90 | 3.20±0.93 | 0.571 | −0.03 | −0.03 | −0.07** | −0.03 |
| HDL-C, mg/dL | 1.34 (1.16, 1.54) | 1.20 (1.06, 1.39) | <0.001** | 0.13** | −0.03 | 0.24** | 0.11 |
| FBG, mg/dL | 5.06 (4.74, 5.47) | 5.44 (5.05, 6.04) | <0.001** | 0.04 | −0.01 | 0.13** | 0.04 |
| VOmax, mL/kg·min | 31.90±5.17 | 31.19±4.51 | 0.06 | – | – | – | – |
| RGS | 1.62±0.35 | 1.43±0.30 | <0.001** | – | – | – | – |
| * ** NAFLD – non-alcoholic fatty liver disease; VOmax – maximal oxygen uptake; RGS – relative grip strength; BMI – body mass index; WHR – waist-to-hip ratio; SBP – systolic blood pressure; DBP – diastolic blood pressure; TC – total cholesterol; TG – triglyceride; HDL-C – high-density lipoprotein cholesterol; LDL-C – low-density lipoprotein cholesterol; FBG – fasting blood-glucose. | |||||||






